Sensex Rises Over 100 Points, Dow Futures Trade Flat

Molnupiravir, an antiviral drug, was initially developed for the treatment of influenza. It is repurposed to completely suppress the transmission of the Covid-19 virus within 24 hours, according to a recent study published in the journal Nature Microbiology.

The synthetic process know-how for Molnupiravir was sourced from CSIR-NIIST and the scale-up process was successfully carried out by CSIR-IICT.

The complete technology know-how will be transferred to Suven Pharmaceuticals, which will in turn manufacture and launch the drug in the domestic market as an effective medication for Covid-19 infected patients.

How this pans out remains to be seen. Meanwhile, stay tuned for more updates from this space.


1 2 3
View single page >> |

And to know what's moving the Indian stock markets today, check out the most recent  more

How did you like this article? Let us know so we can better customize your reading experience.


Leave a comment to automatically be entered into our contest to win a free Echo Show.